Abstract
Purpose: Analysis of the nasopharyngeal carcinoma public transcriptome revealed JAK2 was significantly upregulated in tumors, which encouraged us to investigate its prognostic significance and mutational status. Materials & methods: We assessed the immune-expression of JAK2 and its relationships with various clinicopathological parameters. JAK2 mutation was detected by PCR followed by sequencing. Results: High expression of JAK2 was significantly associated with advanced tumor staging (p = 0.019). JAK2 overexpression acted as an independent predictor for worse disease-specific survival (p = 0.005), distant metastasis-free survival (p = 0.036), local recurrence-free survival (p = 0.012) and overall survival (p = 0.007). JAK2 mutation was not detected in selected cases with JAK2 protein overexpression. Conclusion: JAK2 can serve as a valuable negative prognostic factor and a potential therapeutic target.
Original language | English |
---|---|
Pages (from-to) | 1887-1896 |
Number of pages | 10 |
Journal | Future Oncology |
Volume | 12 |
Issue number | 16 |
DOIs | |
Publication status | Published - Aug 2016 |
Externally published | Yes |
Keywords
- JAK2
- Janus kinase
- nasopharyngeal carcinoma
- prognosis
- transcriptome
ASJC Scopus subject areas
- Oncology
- Cancer Research